China’s Supreme People’s Court consults on evidence admissibility in patent validity proceedings
We spoke to lawyers in China to ask what the guidelines mean for patent litigation, especially in chemical/pharmaceutical cases
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: